Abstract
Numerous herbal products have been the subject of research regarding their potential role in cancer prevention or adjuvant therapy. Pistacia atlantica and its main phytochemicals have garnered significant attention for their potential anti-cancer effects. The study aimed to assess the growth inhibitory effects of P. atlantica essential oil (PAEO) on MKN-45 and AGS cells. This study quantified the volatile compounds in PAEO using Gas Chromatography–Mass Spectrometry (GC–MS). Subsequently, MKN-45 and AGS cells were treated with varying concentrations of PAEO (5%, 2.5%, 1.25%, 0.625%, 0.3125%, 0.156%, 0.0781%, 0.0391%, 0.0195%) for 24 h. Cell viability was evaluated through the MTT assay. The impact of PAEO on gene expression was investigated by quantifying the mRNA levels of Bax and Bcl2 in the various experimental groups using quantitative Real-Time PCR (qRT-PCR) analysis. Additionally, flow cytometry was utilized to evaluate apoptosis in the treated cells. The analysis of PAEO revealed that α-pinene was the predominant monoterpene, constituting 87.9% of the oil composition. The cytotoxic effects of PAEO were evaluated, and it was found that the oil significantly reduced the viability of MKN-45 and AGS cells. The IC50 for MKN-45 cells was determined to be 1.94 × 10–3% after 24 h of treatment, while for AGS cells the IC50 was 2.8 × 10–3% after 24 h. Additionally, the research revealed that PAEO triggered a notable rise in apoptotic cells in both AGS and MKN-45 cell lines. Moreover, at the molecular level, the findings indicated an increase in Bax expression and a decrease in Bcl2 mRNA expression, providing further evidence of the induction of apoptosis in both MKN-45 and AGS cell lines following PAEO treatment. The findings of this study offer evidence supporting the cytotoxic effects of PAEO on gastric cancer cell lines by promoting apoptosis. The findings suggest that PAEO may offer potential as a therapeutic candidate in managing and treating gastric cancer.
Similar content being viewed by others
Data availability
Not applicable.
References
Pitolli C, Wang Y, Mancini M, Shi Y, Melino G, Amelio I. Do mutations turn p53 into an oncogene? Int J Mol Sci. 2019;20(24):6241.
Marvalim C, Datta A, Lee SC. Role of p53 in breast cancer progression: an insight into p53 targeted therapy. Theranostics. 2023;13(4):1421–42.
Barabutis N, Schally AV, Siejka A. P53, GHRH, inflammation and cancer. EBioMedicine. 2018;37:557–62.
Meric-Bernstam F, Zheng X, Shariati M, Damodaran S, Wathoo C, Brusco L, et al. Survival outcomes by TP53 mutation status in metastatic breast cancer. JCO Precis Oncol. 2018;2018:PO.17.00245.
Coutzac C, Pernot S, Chaput N, Zaanan A. Immunotherapy in advanced gastric cancer, is it the future? Crit Rev Oncol Hematol. 2019;133:25–32.
Demain AL, Vaishnav P. Natural products for cancer chemotherapy. Microb Biotechnol. 2011;4(6):687–99.
Mozaffarpur SA, Naseri M, Kamalinejad M, Shams MA, Memariani Z, Moeini R, et al. Nine steps to discover new medicines from traditional sources: the example of Persian medicine. J Altern Complement Med. 2020;26(5):365–8.
Rajesh E, Sankari LS, Malathi L, Krupaa JR. Naturally occurring products in cancer therapy. J Pharm Bioallied Sci. 2015;7(Suppl 1):S181–3.
Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009;27(16):2712–25.
Pasban-Aliabadi H, Sobhani V, Esmaeili-Mahani S, Najafipour H, Askari A, Jalalian H. Effects of Baneh (Pistacia atlantica) gum on human breast cancer cell line (MCF-7) and its interaction with anticancer drug doxorubicin. Iran J Pharm Res. 2019;18(4):e124693.
Memariani Z, Gorji N, Moeini R, Farzaei MH, et al. Traditional uses. In: Nabavi SM, et al., editors. Phytonutrients in food. Elsevier; 2020. p. 23–66.
Daneshrad A, Aynehchi Y. Chemical studies of the oil from pistacia nuts growing wild in Iran. J Am Oil Chem Soc. 1980;57(8):248–9.
Eghbali-Feriz S, Taleghani A, Al-Najjar H, Emami SA, Rahimi H, Asili J, et al. Anti-melanogenesis and anti-tyrosinase properties of Pistacia atlantica subsp. mutica extracts on B16F10 murine melanoma cells. Res Pharm Sci. 2018;13(6):533.
Mahmoudzadeh A, Mohammadpour H. Tumor cell culture on collagen–chitosan scaffolds as three-dimensional tumor model: a suitable model for tumor studies. J Food Drug Anal. 2016;24(3):620–6.
Karkanrood MV, Homayouni Tabrizi M, Ardalan T, Soltani M, Khadem F, Nosrat T, et al. Pistacia atlantica fruit essential oil nanoemulsions (PAEO-NE), an effective antiangiogenic therapeutic and cell-dependent apoptosis inducer on A549 human lung cancer cells. Inorg Nano-Metal Chem. 2022. https://doi.org/10.1080/24701556.2022.2034008.
Rezaei PF, Fouladdel S, Ghaffari SM, Amin G, Azizi E. Induction of G1 cell cycle arrest and cyclin D1 down-regulation in response to pericarp extract of Baneh in human breast cancer T47D cells. Daru. 2012;20(1):101.
Rezaei PF, Fouladdel S, Hassani S, Yousefbeyk F, Ghaffari SM, Amin G, et al. Induction of apoptosis and cell cycle arrest by pericarp polyphenol-rich extract of Baneh in human colon carcinoma HT29 cells. Food Chem Toxicol. 2012;50(3):1054–9.
Mohtashami R, Hashem-Dabaghian F, Nabati F, Qaderi A, Kianbakht S. Efficacy of topical oleoresin of Pistacia atlantica L. subspecies kurdica for symptomatic relief of knee osteoarthritis: a randomized double-blinded controlled trial. J Herb Med. 2023;38:100638.
Ahmed ZB, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Vander HY. Four Pistacia atlantica subspecies (atlantica, cabulica, kurdica and mutica): a review of their botany, ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol. 2021;265:113329.
Rauf A, Al-Awthan YS, Muhammad N, Shah MM, Mitra S, Emran TB, et al. Pharmacological investigation of genus Pistacia. Nat Med Plants. 2022;2022:117.
Tilkat EA, Batibay H, Yener I, Yilmaz PK, Akdeniz M, Kaplan A, et al. Determination of enzyme inhibition potential and anticancer effects of Pistacia khinjuk stocks raised in in vitro and in vivo conditions. Agronomy. 2021;11(1):154.
Adams RP. Identification of essential oil components by gas chromatography/quadrupole mass spectroscopy. Wheaton, IL: Allured Publishing Corporation; 2001.
McLafferty FW, Stauffer DB. The Wiley/NBS registry of mass spectral data. New York: Wiley; 1989.
Ferrari M, Fornasiero MC, Isetta AM. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods. 1990;131(2):165–72.
Liu B, Han L, Liu J, Han S, Chen Z, Jiang L. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer. Int J Nanomed. 2017;12:955–68.
Memariani Z, Sharifzadeh M, Bozorgi M, Hajimahmoodi M, Farzaei MH, Gholami M, et al. Protective effect of essential oil of Pistacia atlantica Desf. on peptic ulcer: role of α-pinene. J Tradit Chin Med. 2017;37(1):57–63.
Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020;177(6):1409–23.
Najjari N, Sari S, Saffari M, Kelidari H, Nokhodchi A. Formulation optimization and characterization of Pistacia atlantica Desf. essential oil-loaded nanostructured lipid carriers on the proliferation of human breast cancer cell line SKBR3 (in vitro studies). J Herb Med. 2022;36:100600.
Chen W-Q, Xu B, Mao J-W, Wei F-X, Li M, Liu T, et al. Inhibitory effects of α-pinene on hepatoma carcinoma cell proliferation. Asian Pac J Cancer Prev. 2014;15(7):3293–7.
Zhao Y, Chen R, Wang Y, Yang Y. α-Pinene inhibits human prostate cancer growth in a mouse xenograft model. Chemotherapy. 2018;63(1):1–7.
Rahman HS. Phytochemical analysis and antioxidant and anticancer activities of mastic gum resin from Pistacia atlantica subspecies kurdica. Onco Targets Ther. 2018;11:4559–72.
Spyridopoulou K, Tiptiri-Kourpeti A, Lampri E, Fitsiou E, Vasileiadis S, Vamvakias M, et al. Dietary mastic oil extracted from Pistacia lentiscus var. chia suppresses tumor growth in experimental colon cancer models. Sci Rep. 2017;7(1):1–14.
Yemmen M, Nguyen PH, Ayadi MT, Mégraud F, Varon C. Antiproliferative and proapoptotic effects of leaf, fruit and stem extracts of Pistacia lentiscus on human colon and gastric cancer cell lines. Int J Adv Pharm Biol Chem. 2015;4(4):737–45.
Acknowledgements
The authors would like to thank the staff members of Babol University of Medical Science, Iran, for their help and support.
Funding
This project was supported by Babol University of Medical Science, Babol, Iran (Number: 9808016).
Author information
Authors and Affiliations
Contributions
FS: Methodology, Data analysis, wrote the draft. MS: Writing - Editing, Supervision. MJK: Methodology, Writing—Editing. MAM: Data analysis, Investigation. SK: Data curation, Analysis. FS: Validation, Data analysis. EZN: Software. Review. RM: Resources. Prepared figures. NG: Data analysis, Editing. ZM: Conceptualization, Methodology, Writing—Review & Editing, Supervision. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors confirm that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Saeedi, F., Salehi, M., Kamali, M.J. et al. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines. Med Oncol 41, 148 (2024). https://doi.org/10.1007/s12032-024-02339-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-024-02339-z